Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 691, pseudogene (RN7SL691P) is a non-protein-coding pseudogene, classified as a processed pseudogene related to the 7SL RNA gene, which forms part of the signal recognition particle (SRP) RNA family[1][4]. The 7SL RNA is essential for protein targeting to the endoplasmic reticulum in its functional (non-pseudogene) form, but most 7SL pseudogenes, including RN7SL691P, do not produce functional RNA molecules and are generally not transcribed or translated into protein[1][6]. Pseudogenes like RN7SL691P usually have no or very limited biological activity, but some pseudogenes in general may be transcribed and—rarely—act as non-coding competing endogenous RNAs, modulating microRNA availability and potentially affecting expression of related genes[2]. RN7SL691P itself has no evidence supporting a role as a therapeutic target, nor is it associated with any known disease role, biomarker status, or drug interaction[1][4][6]. The gene is located on chromosome 4 (GRCh38: 43,598,544-43,598,844, reverse strand)[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 691, pseudogene (RN7SL691P).